Company intelligence / Profile preview

Precision Preventive Cardiology

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Precision Preventive Cardiology delivers comprehensive, patient-centered preventive cardiology care led by Dr. Danielle Belardo, focusing on evidence-based management of cardiovascular risk factors, advanced lipidology, hypertension, weight loss, and nutrition, with services available in office and via telehealth. They focus on lifestyle interventions as well as medical therapy where indicated, but do not conduct drug development or formal clinical trials[1][2][3][6].

Therapeutic areas: CardiovascularEndocrinology
Modalities: Non-pharmacological therapySmall molecule
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Precision Preventive Cardiology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Precision Preventive Cardiology.

Explore the full profile